Seres Therapeutics to Present at Two Upcoming March Conferences
March 09 2018 - 7:00AM
Business Wire
Seres Therapeutics, Inc. (NASDAQ:MCRB) today announced it will
present at each of the following upcoming healthcare
conferences:
- The 38th Annual Cowen
& Co. Health Care Conference: a corporate overview will be
presented on Wednesday, March 14 at 10:40 a.m. ET in Boston,
MA.
- Oppenheimer's 28th
Annual Healthcare Conference: a corporate overview will be
presented on Tuesday, March 20 at 10:20 a.m. ET in New York,
NY.
A live audio webcast of each presentation will be available
under the “Investors and Media” section of Seres’ website. A replay
of each presentation will become available approximately one hour
after the event and will be archived for 21 days.
About Seres TherapeuticsSeres Therapeutics, Inc., is
a leading microbiome therapeutics platform company developing a
novel class of biological drugs that are designed to treat disease
by restoring the function of a dysbiotic microbiome, where the
natural state of bacterial diversity and function is imbalanced.
Seres’ lead program, SER-109, has obtained Breakthrough Therapy and
Orphan Drug designations from the U.S. Food and Drug Administration
and is in Phase 3 development for multiply recurrent C. difficile
infection. Seres’ clinical candidate SER-287 has successfully
completed a Phase 1b study in patients with mild-to-moderate
Ulcerative Colitis and has obtained Orphan Drug designation for
pediatric Ulcerative Colitis. Seres is also developing SER-262, the
first ever synthetic microbiome therapeutic candidate, in a Phase
1b study in patients with primary C. difficile infection and is
developing SER-401 to enhance the efficacy of checkpoint inhibitors
in patients with certain tumors. For more information, please visit
www.serestherapeutics.com. Follow us on Twitter @SeresTx.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20180309005031/en/
Seres TherapeuticsCarlo Tanzi, Ph.D., 617-203-3467Vice
President, Investor Relations and Corporate
Communicationsctanzi@serestherapeutics.com
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From Apr 2024 to May 2024
Seres Therapeutics (NASDAQ:MCRB)
Historical Stock Chart
From May 2023 to May 2024